The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.
Open Access
- 1 February 1993
- journal article
- guideline
- Published by BMJ in Journal of Clinical Pathology
- Vol. 46 (2), 97-103
- https://doi.org/10.1136/jcp.46.2.97
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Protamine—the need to determine the doseAnaesthesia, 1991
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart ValvesNew England Journal of Medicine, 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983
- Pregnancy in Women with Congenital Antithrombin III Deficiency: Experience of Treatment with Heparin and AntithrombinGynecologic and Obstetric Investigation, 1982
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980